AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 112 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,582,693 | -39.3% | 248,071 | +5.5% | 0.00% | – |
Q2 2023 | $2,608,767 | +18.1% | 235,236 | +63.5% | 0.00% | – |
Q1 2023 | $2,208,404 | -28.1% | 143,870 | +3.9% | 0.00% | -100.0% |
Q4 2022 | $3,071,296 | -5.1% | 138,409 | -30.2% | 0.00% | 0.0% |
Q3 2022 | $3,238,000 | -79.1% | 198,293 | -81.4% | 0.00% | -66.7% |
Q2 2022 | $15,521,000 | -26.0% | 1,068,223 | -5.9% | 0.00% | -25.0% |
Q1 2022 | $20,977,000 | -13.8% | 1,135,744 | +10.9% | 0.00% | 0.0% |
Q4 2021 | $24,333,000 | +62.2% | 1,023,720 | +68.0% | 0.00% | +33.3% |
Q3 2021 | $15,006,000 | +29.9% | 609,263 | +30.3% | 0.00% | +50.0% |
Q2 2021 | $11,552,000 | +67.6% | 467,456 | +47.9% | 0.00% | +100.0% |
Q1 2021 | $6,892,000 | -50.1% | 316,011 | -41.6% | 0.00% | -66.7% |
Q4 2020 | $13,816,000 | -34.4% | 541,415 | -27.6% | 0.00% | -25.0% |
Q3 2020 | $21,059,000 | -14.8% | 748,107 | -14.5% | 0.00% | -33.3% |
Q2 2020 | $24,729,000 | – | 875,088 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
AtonRa Partners | 18,970 | $121,029 | 0.25% |
Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |